Upgrade

Tempest Therapeutics, Inc.

TPST

Last
$0.76
Day
-1.3%
1y
-92.9%
5y
-99.6%
52w
-93.7%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-0425d
EMA 21
0.85
EMA 50
0.94
EMA 200
2.39
20d high
-48.0%
5y high
-99.6%
5y range
0th
Website · 4 employees · United States

Positions held

Your positions

TPST isn't in your positions.

Add it to see shares, cost, and P&L here.

Score
-24
Hold
avoid
Signal
Strong Sell
Target
$0.90
Stop
$0.66
Stop distance
13.2%
Target vs last
+18.4%

Fundamentals

Market cap$13.01MEnterprise value$19.09MTrailing P/E—Forward P/E-0.64
PEG—Price / book13.51Beta-1.71Dividend yield0.00%
Revenue growth—Earnings growth—Gross margin0.0%Operating margin0.0%
Profit margin0.0%ROE-9.3%ROA-79.4%Debt / equity—
Current ratio0.38Free cash flow-$15.51MAnalyst recommendationstrong_buyMean target$7.00
52w high$12.2352w low$0.74

Quarterly

2026-Q22026-Q12025-Q42025-Q32025-Q22025-Q1
Revenue$0.0M$0.0M$0.0M$0.0M$0.0M—
Op margin——————
Net income-$5.2M-$27.7M-$4.0M-$3.5M-$7.9M—
Gross margin——————
Gross profit——————
Operating income-$5.3M-$5.5M-$4.1M-$3.6M-$8.0M—

Yearly (6y)

20252024202320222021
Revenue$0.0M$0.0M$0.0M$0.0M—
Op margin—————
Net income-$26.3M-$41.8M-$29.5M-$35.7M—
Gross margin—————
Gross profit—————
Operating income-$26.6M-$42.0M-$29.2M-$34.6M—
Headline scan

No flags

• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).

News

TPST · daily-23.0% over 13 sessions
Close EMA21 EMA50 EMA200
0.730.830.921.011.112026-092026-092026-092026-092026-102026-102026-10
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin
-$28M-$21M-$14M-$7M$0M0%5%10%2025-Q22025-Q32025-Q42026-Q12026-Q2